Sanofi, Glaxo to Supply U.K.; China Cases Up: Virus Update

Sanofi and GlaxoSmithKline Plc, partners developing a potential coronavirus vaccine, agreed to supply the U.K. with up to 60 million doses of their experimental vaccine. The U.S. neared 150,000 deaths even as daily infections slowed in some hard-hit states.